XML 40 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Financial Statements - Schedule of Statements of Operations Data (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues $ 1,663,496 $ 1,500,673 $ 4,783,003 $ 4,289,780
Income from operations 626,923 559,926 1,816,342 1,540,780
Income before income taxes 635,861 565,605 1,877,333 1,523,744
Income tax expense (41,206) (177,288) (253,286) (498,752)
Net income 594,655 388,317 1,624,047 1,024,992
Collaboration and contract manufacturing        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Cost of goods sold 79,552 57,844 180,918 141,547
Balance Without Adoption of ASC 606        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 1,700,242   4,755,229  
Income from operations 681,187   1,806,086  
Income before income taxes 690,125   1,867,077  
Income tax expense (43,869)   (248,656)  
Net income 646,256   1,618,421  
Balance Without Adoption of ASC 606 | Collaboration and contract manufacturing        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Cost of goods sold 62,034   163,400  
Accounting Standards Update 2014-09 | Adjustments        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 36,746   (27,774)  
Income from operations 54,264   (10,256)  
Income before income taxes 54,264   (10,256)  
Income tax expense (2,663)   4,630  
Net income 51,601   (5,626)  
Accounting Standards Update 2014-09 | Adjustments | Collaboration and contract manufacturing        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Cost of goods sold (17,518)   (17,518)  
Sanofi | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 256,265 245,175 683,508 677,670
Sanofi | Balance Without Adoption of ASC 606 | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 268,437   678,349  
Sanofi | Accounting Standards Update 2014-09 | Adjustments | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 12,172   (5,159)  
Other | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 117,370 $ 61,506 314,552 $ 231,446
Other | Balance Without Adoption of ASC 606 | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues 141,944   291,937  
Other | Accounting Standards Update 2014-09 | Adjustments | Product and service, other        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Revenues $ 24,574   $ (22,615)